Back to IONS
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
1 competitor in Cytomegalovirus Retinitis
View Full LandscapeDrug Information
Patent & Exclusivity
Regulatory Approvals
EMA7/29/1999
Vitravene
For the local treatment of cytomegalovirus (CMV) retinitis in patients with acquired immuno-deficiency syndrome (AIDS). Until further experience is gained, fomivirsen should be used only when other therapy has been ineffective or is considered unsuitable.
View on EMADrug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts